55 results
F-3
SCNI
Scinai Immunotherapeutics Ltd
30 Jan 24
Shelf registration (foreign)
4:19pm
in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We take no responsibility for, and can
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
8:24am
in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We take no responsibility
F-1/A
SCNI
Scinai Immunotherapeutics Ltd
22 Dec 23
Registration statement (foreign) (amended)
9:11am
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should not assume
F-1
SCNI
Scinai Immunotherapeutics Ltd
30 Oct 23
Registration statement (foreign)
4:59pm
that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We take no responsibility
6-K
EX-1.1
ws39sce 5aatba
19 Sep 23
Report of Foreign Private Issuer
3:06pm
424B5
cqdzkpvcrke8z
19 Sep 23
Prospectus supplement for primary offering
10:03am
10-Q
zt9wkabj4e vc9
15 May 23
Quarterly report
4:49pm
10-K
kk9jpmdeubz
17 Apr 23
Annual report
4:06pm
10-K
EX-14.1
mpa guhaeh
17 Apr 23
Annual report
4:06pm
6-K
EX-1.1
zw9rjn6wxps0l0cn514k
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
6h8 sys2d
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-1.1
n4b17716now6wq
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
hkuvyn
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
F-1
pazpkhnk ahixjw4
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-1.1
grqgwkij1oz 6mhnn8c
29 Dec 21
Report of Foreign Private Issuer
6:06am